Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer

doi:10.3748/wjg.v20.i21.6691

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 21

This Article

(385)

(332)

(0)

(6265)

(14)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Gastroenterol. Jun 7, 2014; 20(21): 6691-6697
Published online Jun 7, 2014. doi: 10.3748/wjg.v20.i21.6691

Full Size Figure Download Figure

Figure 1 Brain enhanced computed tomography scan of case 1 (8 h after coma). A mild degree of cerebral atrophy; no remarkable intracranial metastases were found.

Citation: Wang W, Zhao LR, Lin XQ, Feng F. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer. World J Gastroenterol 2014; 20(21): 6691-6697
URL: https://www.wjgnet.com/1007-9327/full/v20/i21/6691.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i21.6691

Wang W, Zhao LR, Lin XQ, Feng F. Reversible posterior leukoencephalopathy syndrome induced by bevacizumab plus chemotherapy in colorectal cancer. World J Gastroenterol 2014; 20(21): 6691-6697 [PMID: 24914397 DOI: 10.3748/wjg.v20.i21.6691]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.